Google invests millions in Mark Zuckerberg’s efforts to create a ‘virtual cell’
Google DeepMind, Meta, and Isomorphic Labs are investing $300 million into Biohub to advance the creation of a 'virtual cell' for biological simulations. The initiative is supported by significant federal funding and aims to accelerate disease research through digital experimentation.
Why it matters
This collaboration represents a major intersection of big tech and biomedical research, potentially revolutionizing drug discovery and disease prevention.
Google DeepMind, Meta, and AI drug discovery startup Isomorphic Labs are jointly investing $300 million into Biohub, the nonprofit biomedical research organization founded by Mark Zuckerberg and his wife, Priscilla Chan, as reported by Reuters. The funding is part of a $1.8 billion initiative to build AI datasets that could allow researchers to “ask, predict, and answer biological questions digitally,” helping find new ways to prevent and manage diseases.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in